Association of Macular Pigment Optical Density (MPOD) and Genetic Variants in Complement Factor H in Subjects With Choroidal Neovascular (CNV)

Completed

Conditions studied: Age-related Macular Degeneration, Choroidal Neovascular Age-related Macular Degeneration

In brief

Subjects with wet AMD, dry AMD, and age-matched controls will undergo routine occular measurements, will provide a blood and cheek cell sample, and will have macular pigment optical density (MPOD) measured to determine if there is an association between genetics, MPOD and the risk of progression to wet AMD.

Key facts

Study ID

NCT01682382

Run by

Sequenom, Inc.

People needed

45

Starts

2012-08-01

Expected to finish

2013-10-01

Last updated by the study team

2014-01-20

Who can join

Age: 60 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• subject is diagnosed with either CNV, dry AMD or is an age-matched control
• self reported as non-Hispanic Caucasian
• 60 years of age or older
• provides signed and dated informed consent
• agrees to provide 10 mL of whole blood and two buccal swabs

You may not qualify if…

• previous donation under this protocol

Where it is running

• Morris Eye Group — Encinitas, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.